Can Fite Biopharma Ltd logo

Can Fite Biopharma Ltd

NEW
XTAE:CANF (Israel)  
₪ 5.14 +0.16 (+3.26%) Aug 6
At Loss
P/B:
0.80
Market Cap:
₪ 22.01M ($ 7.33M)
Enterprise V:
₪ -3.51M ($ -1.17M)
Volume:
34.14K
Avg Vol (2M):
32.28K
Trade In:
Volume:
34.14K
At Loss

Can Fite Biopharma Ltd (XTAE:CANF) Dividend

Can Fite Biopharma Ltd (XTAE:CANF) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -112.7%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: XTAE:CANF Dividend

Does Can Fite Biopharma Ltd (XTAE:CANF) pay a dividend?

Can Fite Biopharma Ltd (XTAE:CANF) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Can Fite Biopharma Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Can Fite Biopharma Ltd has returned capital to shareholders via buybacks at a rate of -112.7% over the past 3 years.

What are dividend-paying alternatives to Can Fite Biopharma Ltd?

For dividend-paying alternatives in Can Fite Biopharma Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.